Literature DB >> 9600059

Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice.

E Segi1, Y Sugimoto, A Yamasaki, Y Aze, H Oida, T Nishimura, T Murata, T Matsuoka, F Ushikubi, M Hirose, T Tanaka, N Yoshida, S Narumiya, A Ichikawa.   

Abstract

The physiological role of the prostaglandin E2 receptor EP4 subtype was investigated by generation of EP4-deficient-mice by gene targeting. Loss of the EP4 receptor was not lethal in utero, but most EP4 (-/-) neonates became pale and lethargic approximately 24 h after birth and died within 72 h. Less than 5% of the EP4 (-/-) mice survived and grew normally more than a year. Histological examination revealed that the ductus arteriosus in dead neonates remained open, while it was partially closed in the survivors. In situ hybridization study showed that EP4 mRNA was strongly expressed in the ductus. These results suggest that neonatal death is at least partly due to patent ductus arteriosus and that the EP4 receptor plays a role in regulation of the patency of this vessel. They also indicate that normal function of the EP4 receptor is essential in neonatal adaptation of the circulatory system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600059     DOI: 10.1006/bbrc.1998.8461

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  77 in total

Review 1.  Genetic and pharmacological analysis of prostanoid receptor function.

Authors:  S Narumiya; G A FitzGerald
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Not a mouse stirring: deletion of the EP2 and love's labor's lost.

Authors:  S Austin; G A FitzGerald
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  Which of the n-3 FA should be called essential?

Authors:  Lotte Lauritzen; Harald S Hansen
Journal:  Lipids       Date:  2003-08       Impact factor: 1.880

Review 4.  Cyclooxygenases and lipoxygenases in cancer.

Authors:  Claus Schneider; Ambra Pozzi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

5.  Identification of candidate maternal-effect genes through comparison of multiple microarray data sets.

Authors:  Jesse Mager; Richard M Schultz; Brian P Brunk; Marisa S Bartolomei
Journal:  Mamm Genome       Date:  2006-09-08       Impact factor: 2.957

Review 6.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

7.  Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes.

Authors:  Yoko Matsuoka; Tomoyuki Furuyashiki; Haruhiko Bito; Fumitaka Ushikubi; Yasuhiro Tanaka; Takuya Kobayashi; Seiji Muro; Noriko Satoh; Tetsuro Kayahara; Mikito Higashi; Akira Mizoguchi; Hitoshi Shichi; Yoshihiro Fukuda; Kazuwa Nakao; Shuh Narumiya
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

8.  The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage.

Authors:  Elsa-Marie Treutlein; Katharina Kern; Andreas Weigert; Neda Tarighi; Claus-Dieter Schuh; Rolf M Nüsing; Yannick Schreiber; Nerea Ferreirós; Bernhard Brüne; Gerd Geisslinger; Sandra Pierre; Klaus Scholich
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

9.  Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice.

Authors:  Hee-Yoon Chang; Joseph Locker; Run Lu; Victor L Schuster
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

10.  Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta.

Authors:  Toru Oga; Toshiyuki Matsuoka; Chengcan Yao; Kimiko Nonomura; Shiho Kitaoka; Daiji Sakata; Yoshihiro Kita; Kiminobu Tanizawa; Yoshio Taguchi; Kazuo Chin; Michiaki Mishima; Takao Shimizu; Shuh Narumiya
Journal:  Nat Med       Date:  2009-11-29       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.